Haya Therapeutics

Eli Lilly bets $1B in biobucks on Haya to scour dark genome for obesity targets
Fierce Biotech
Wed, 09/4/24 - 11:37 am
Eli Lilly
Haya Therapeutics
dark genome
obesity
drug discovery
A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto
Endpoints
Thu, 05/20/21 - 11:04 pm
RNA
Haya Therapeutics